Mesenchymal stromal cell-derived extracellular vesicles alleviate immune checkpoint inhibitor-related pneumonitis by regulating macrophage inflammasome activation
DOI：10.3872/j.issn.1007-385x.2026.05.006
- VernacularTitle:间充质基质细胞外囊泡通过调控巨噬细胞炎症小体改善免疫检查点抑制剂相关肺炎
- Author:
XIAO Shuyan1,2
1
,
2
,
3
;
XUE Fengyuan1
1
,
2
,
3
;
JI Yinmin3
1
,
2
,
3
;
LYU Yahui1
1
,
2
,
3
;
DONG Yi1,2
1
,
2
,
3
;
HU Yi2,3
1
,
2
,
3
Author Information
1. Department of Clinical Medicine, Medical School of Chinese People's Liberation Army, Beijing 100853, China;
2. Department of Medical Oncology, The First Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100853, China;
3. Department of Oncology, The Fifth Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100039, China
- Publication Type:Journal Article
- Keywords:
细胞外囊泡；间充质基质细胞；免疫检查点抑制剂相关肺炎；巨噬细胞；NLRP3炎症小体
- From:
Chinese Journal of Cancer Biotherapy
2026;33(5):521-527
- CountryChina
- Language:Chinese
-
Abstract:
[摘 要] 目的：探讨间充质基质细胞来源细胞外囊泡（MSC-EV）对小鼠免疫检查点抑制剂相关肺炎（CIP）模型的改善作用及分子机制。方法：选取Foxp3DTR小鼠，皮下接种MC38小鼠结肠癌细胞，待肿瘤生长至可触及后，随机分为3组（每组n = 6）：①对照组；②CIP模型组[接种MC38细胞后腹腔注射白喉毒素（DT）及anti-PD-1抗体，构建Treg细胞耗竭联合anti-PD-1抗体诱导的小鼠CIP模型]；③MSC-EV干预组（CIP模型基础上，经鼻滴注MSC-EV干预，剂量109个/只，每3天1次，共2次）。体内实验采用H-E染色观察肺组织病理损伤，测定肺干湿比评估肺水肿程度，ELISA检测支气管肺泡灌洗液（BALF）中IL-1β、IL-6及TNF-α水平，流式细胞术检测BALF中Ly6G⁺粒细胞浸润比例，监测肿瘤体积评价抗肿瘤疗效。体外实验采用DiO荧光标记观察细胞外囊泡（EV）被骨髓来源巨噬细胞摄取的情况，WB法检测NOD样受体家族含Pyrin域蛋白3（NLRP3）炎症小体关键蛋白（剪切型GSDMD、成熟型IL-1β）的表达水平。结合GEO数据库miRNA测序数据（GSE69909）、Dicer敲低及miR-21/miR-125抑制剂干预揭示潜在机制。结果：MSC-EV经鼻滴注可减轻CIP模型小鼠肺部炎症损伤，降低BALF中IL-1β、IL-6、TNF-α水平及Ly6G⁺粒细胞浸润比例（P < 0.05），且不削弱anti-PD-1抗体的抗肿瘤疗效。体外DiO标记示踪显示MSC-EV可被巨噬细胞摄取，WB法检测结果显示，MSC-EV可降低NLRP3炎症小体关键活化蛋白（剪切型GSDMD、成熟型IL-1β）水平（P < 0.05）。体外实验中，Dicer敲低后制备的MSC-EV 对巨噬细胞IL-1β的下调作用减弱（P < 0.05）。miRNA测序显示miR-21、miR-125在MSC-EV中高表达，抑制miR-21或miR-125后，相应MSC-EV对巨噬细胞IL-1β剪切的抑制作用降低（P < 0.05）。结论：MSC-EV通过其携带的miR-21和miR-125等miRNA发挥抗炎效应，其机制可能与抑制巨噬细胞NLRP3炎症小体活化有关，可有效改善CIP且不影响免疫检查点抑制剂的抗肿瘤疗效。
- Full text:20260616085729550420260506.pdf
